251 related articles for article (PubMed ID: 30611787)
1. Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug repurposing study.
Boyapally R; Pulivendala G; Bale S; Godugu C
Life Sci; 2019 Mar; 220():8-20. PubMed ID: 30611787
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
4. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.
Pulivendala G; Bale S; Godugu C
Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644
[TBL] [Abstract][Full Text] [Related]
5. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
6. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
[No Abstract] [Full Text] [Related]
7. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
8. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
9. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway.
Liu X; Shao Y; Zhang X; Ji X; Xie M; Liu H
Acta Histochem; 2021 Jul; 123(5):151746. PubMed ID: 34217047
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Wnt/β-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis.
Cao H; Wang C; Chen X; Hou J; Xiang Z; Shen Y; Han X
Sci Rep; 2018 Sep; 8(1):13644. PubMed ID: 30206265
[TBL] [Abstract][Full Text] [Related]
11.
Huang G; Zhang J; Qing G; Liu D; Wang X; Chen Y; Li Y; Guo S
DNA Cell Biol; 2021 Jan; 40(1):18-25. PubMed ID: 33306933
[TBL] [Abstract][Full Text] [Related]
12. The role of WNT/β-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl
El-Ashmawy NE; Al-Ashmawy GM; Fakher HE; Khedr NF
Cytokine; 2020 Dec; 136():155250. PubMed ID: 32882667
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
14. Paraquat induces pulmonary fibrosis through Wnt/β-catenin signaling pathway and myofibroblast differentiation.
Sun Z; Yang Z; Wang M; Huang C; Ren Y; Zhang W; Gao F; Cao L; Li L; Nie S
Toxicol Lett; 2020 Oct; 333():170-183. PubMed ID: 32795487
[TBL] [Abstract][Full Text] [Related]
15. HIPK2 attenuates bleomycin-induced pulmonary fibrosis by suppressing the Wnt/β-catenin signaling pathway.
Wang F; Zhang Y; Ren J; Yu W
Folia Histochem Cytobiol; 2022; 60(3):247-259. PubMed ID: 36004621
[TBL] [Abstract][Full Text] [Related]
16. Dehydrozingerone alleviates pulmonary fibrosis via inhibition of inflammation and epithelial-mesenchymal transition by regulating the Wnt/β-catenin pathway.
Shaikh TB; Kuncha M; Andugulapati SB; Sistla R
Eur J Pharmacol; 2023 Aug; 953():175820. PubMed ID: 37245857
[TBL] [Abstract][Full Text] [Related]
17. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis.
Kim TH; Kim SH; Seo JY; Chung H; Kwak HJ; Lee SK; Yoon HJ; Shin DH; Park SS; Sohn JW
Tohoku J Exp Med; 2011 Jan; 223(1):45-54. PubMed ID: 21212602
[TBL] [Abstract][Full Text] [Related]
19. The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression.
Chang X; Zhen X; Liu J; Ren X; Hu Z; Zhou Z; Zhu F; Ding K; Nie J
Kidney Int; 2017 Sep; 92(3):612-624. PubMed ID: 28318631
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway.
Guo L; Peng W; Tao J; Lan Z; Hei H; Tian L; Pan W; Wang L; Zhang X
PLoS One; 2016; 11(1):e0147018. PubMed ID: 26760502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
